Solutions for T Cell Activation and Culture

Cell therapy is the next big step for immuno-oncology, and T cells play a big role in bringing this therapy to patients across the role. Finding the right reagents to isolate, develop, or manufacture T cells while ensuring them to be compliant with the relevant regulations can be a challenge. Currently, the most common types of cell therapies utilizing T cells are CAR-T cells (gene-modified), Tumor-infiltrating Lymphocytes (TILs), and Regulatory T cells (Tregs). Each therapy traditionally uses different reagents to optimize the manufacturing process, as seen below:

Whether you are looking to culture, activate, or perform residue detection in your T cell manufacturing process, ACROBiosystems offers a comprehensive set of solutions including reagents for culturing, activation, and residue detection. Each of our reagents are verified and validated to be high-quality while being specifically designed your manufacturing applications and supporting your cell manufacturing needs.